Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

457 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Testing the 2018 NIA-AA research framework in a retrospective large cohort of patients with cognitive impairment: from biological biomarkers to clinical syndromes.
Carandini T, Arighi A, Sacchi L, Fumagalli GG, Pietroboni AM, Ghezzi L, Colombi A, Scarioni M, Fenoglio C, De Riz MA, Marotta G, Scarpini E, Galimberti D. Carandini T, et al. Among authors: fenoglio c. Alzheimers Res Ther. 2019 Oct 15;11(1):84. doi: 10.1186/s13195-019-0543-7. Alzheimers Res Ther. 2019. PMID: 31615545 Free PMC article.
A novel MAPT mutation associated with the clinical phenotype of progressive nonfluent aphasia.
Villa C, Ghezzi L, Pietroboni AM, Fenoglio C, Cortini F, Serpente M, Cantoni C, Ridolfi E, Marcone A, Benussi L, Ghidoni R, Jacini F, Arighi A, Fumagalli GG, Mandelli A, Binetti G, Cappa S, Bresolin N, Scarpini E, Galimberti D. Villa C, et al. Among authors: fenoglio c. J Alzheimers Dis. 2011;26(1):19-26. doi: 10.3233/JAD-2011-102124. J Alzheimers Dis. 2011. PMID: 21558644
Circulating miRNAs as potential biomarkers in Alzheimer's disease.
Galimberti D, Villa C, Fenoglio C, Serpente M, Ghezzi L, Cioffi SM, Arighi A, Fumagalli G, Scarpini E. Galimberti D, et al. Among authors: fenoglio c. J Alzheimers Dis. 2014;42(4):1261-7. doi: 10.3233/JAD-140756. J Alzheimers Dis. 2014. PMID: 25024331
CSF β-amyloid as a putative biomarker of disease progression in multiple sclerosis.
Pietroboni AM, Schiano di Cola F, Scarioni M, Fenoglio C, Spanò B, Arighi A, Cioffi SM, Oldoni E, De Riz MA, Basilico P, Calvi A, Fumagalli GG, Triulzi F, Galimberti D, Bozzali M, Scarpini E. Pietroboni AM, et al. Among authors: fenoglio c. Mult Scler. 2017 Jul;23(8):1085-1091. doi: 10.1177/1352458516674566. Epub 2016 Oct 17. Mult Scler. 2017. PMID: 27754941
CSF β-amyloid and white matter damage: a new perspective on Alzheimer's disease.
Pietroboni AM, Scarioni M, Carandini T, Basilico P, Cadioli M, Giulietti G, Arighi A, Caprioli M, Serra L, Sina C, Fenoglio C, Ghezzi L, Fumagalli GG, De Riz MA, Calvi A, Triulzi F, Bozzali M, Scarpini E, Galimberti D. Pietroboni AM, et al. Among authors: fenoglio c. J Neurol Neurosurg Psychiatry. 2018 Apr;89(4):352-357. doi: 10.1136/jnnp-2017-316603. Epub 2017 Oct 20. J Neurol Neurosurg Psychiatry. 2018. PMID: 29054920
Distinct patterns of brain atrophy in Genetic Frontotemporal Dementia Initiative (GENFI) cohort revealed by visual rating scales.
Fumagalli GG, Basilico P, Arighi A, Bocchetta M, Dick KM, Cash DM, Harding S, Mercurio M, Fenoglio C, Pietroboni AM, Ghezzi L, van Swieten J, Borroni B, de Mendonça A, Masellis M, Tartaglia MC, Rowe JB, Graff C, Tagliavini F, Frisoni GB, Laforce R Jr, Finger E, Sorbi S, Scarpini E, Rohrer JD, Galimberti D; Genetic FTD Initiative (GENFI). Fumagalli GG, et al. Among authors: fenoglio c. Alzheimers Res Ther. 2018 May 24;10(1):46. doi: 10.1186/s13195-018-0376-9. Alzheimers Res Ther. 2018. PMID: 29793546 Free PMC article.
CSF β-amyloid predicts prognosis in patients with multiple sclerosis.
Pietroboni AM, Caprioli M, Carandini T, Scarioni M, Ghezzi L, Arighi A, Cioffi S, Cinnante C, Fenoglio C, Oldoni E, De Riz MA, Basilico P, Fumagalli GG, Colombi A, Giulietti G, Serra L, Triulzi F, Bozzali M, Scarpini E, Galimberti D. Pietroboni AM, et al. Among authors: fenoglio c. Mult Scler. 2019 Aug;25(9):1223-1231. doi: 10.1177/1352458518791709. Epub 2018 Aug 7. Mult Scler. 2019. PMID: 30084711 Free article.
Amyloid PET as a marker of normal-appearing white matter early damage in multiple sclerosis: correlation with CSF β-amyloid levels and brain volumes.
Pietroboni AM, Carandini T, Colombi A, Mercurio M, Ghezzi L, Giulietti G, Scarioni M, Arighi A, Fenoglio C, De Riz MA, Fumagalli GG, Basilico P, Serpente M, Bozzali M, Scarpini E, Galimberti D, Marotta G. Pietroboni AM, et al. Among authors: fenoglio c. Eur J Nucl Med Mol Imaging. 2019 Feb;46(2):280-287. doi: 10.1007/s00259-018-4182-1. Epub 2018 Oct 21. Eur J Nucl Med Mol Imaging. 2019. PMID: 30343433
457 results